|
|
|
|
| Symbol(s): |
CPHD |
| Date: |
13-May-13 |
| Author: |
Hunter Orr |
| Contributor: |
Alpha Street Research |
| Title: |
CPHD - Cepheid Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report |
| Document Size: |
9 pages |
| Price: |
$24 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $24. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison, and our proprietary ASR Ranking indicating Buy/Sell/Hold. Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.
| | |
|
|
